Anticoagulation therapy: Long-term dabigatran therapy reduces the risk of recurrent venous thromboembolism

Nature Reviews Cardiology 10, 240 (2013). doi:10.1038/nrcardio.2013.33 Author: Megan Cully Effective use of warfarin requires frequent monitoring. Patients treated with dabigatran, a novel oral anticoagulant used to prevent venous thromboembolism (VTE) after joint replacement or to prevent stroke related to atrial fibrillation, do not need to be monitored as often. “Physicians stop anticoagulation after typically

http://feeds.nature.com/~r/nrcardio/rss/current/~3/Vz3-jnFPIhg/nrcardio.2013.33

Source: Nature Reviews Cardiology - March 12, 2013 Category: Cardiology Authors: Megan Cully Tags: Research Highlight Source Type: research